Wisdom Pharmaceutical announced that the company recently received the “Approval to Register Issuance of Shares to Specific Targets” issued by the China Securities Regulatory Commission, agreeing to the company's registration application to issue shares to specific targets. The approval is valid for 12 months from the date of consent to registration.

Wisdom Pharmaceutical announced that the company recently received the “Approval to Register Issuance of Shares to Specific Targets” issued by the China Securities Regulatory Commission, agreeing to the company's registration application to issue shares to specific targets. The approval is valid for 12 months from the date of consent to registration.